68
Jiangsu gdk Biotechnology Co., Ltd.
688670.SS · SHH
¥19.15 +5.10% (+¥0.93)
1M +15.76%
Market Cap ¥2.23B
P/E Ratio -
Div. Yield -
ROE 16.75%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
42 /100
Fair P/B 2.13x
P/S 20.16x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 9.02%
Rev. growth 29.16%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 174.56%
Gross margin 91.54%
FCF margin 141.90%
Quality
1 /100
Poor ROA 14.00%
ROIC 15.74%
Asset turnover 0.08x
Debt
64 /100
Moderate Int. coverage -103.41x
Debt/Equity 0.12x
Current ratio 1.57x
Stability
4 /100
Unstable EPS volatility 125.57%
Beta 0.25x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 688670.SS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jianhui Zhang
Employees
357
Headquarters
Taizhou
Upcoming events
30 OCT
Earnings
Upcoming earnings report